Pharmafile Logo
Pharmafocus logo
Advanced Search
text

Louise Tamblin rejoins Kantar Health

October 4, 2012
Kantar Health, Louise Tamblin

Healthcare-focused consultancy and marketing firm Kantar Health has named Louise Tamblin as group director. Most recently Tamblin was head of …

Appointment

NHS patient care ‘will worsen’

October 4, 2012
Sales and Marketing A&E, MRSA, NHS, king's fund

Patient care will worsen over the next few years and the NHS will not meet its £20 billion productivity target …

News

Sanofi acquires leading Colombian firm

October 4, 2012
Sales and Marketing Columbia, Genfar, Latin America, Sanofi

Sanofi is expanding its presence in Latin American with the acquisition of a Colombian pharma company. Genfar is headquartered in …

News
114053815_tovey_341562c

GW Pharmaceuticals hires chief operating officer

October 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals

GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …

Appointment

Seebri Breezhaler approved in Europe

October 4, 2012
Sales and Marketing COPD, Novartis, Relvar, Seebri Breezhaler, Tudorza

Novartis has been given approval in Europe for its Seebri Breezhaler to be used as maintenance treatment for chronic obstructive …

News
BMS image

Patent losses force change for Sanofi

October 3, 2012
Sales and Marketing Avapro, BMS, Plavix, Sanofi, patent loss

Patent expiries are behind the decision by Sanofi and Bristol-Myers Squibb to radically restructure their long-term corporate alliance. The loss …

News
dame_christine_beasley_282x212

Non-executive directors of NHS Trust appointed

October 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness

Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority.  Ms Beasley (pictured) …

Appointment

Quality issues prompt Sanofi typhoid vaccine recall

October 3, 2012
Manufacturing and Production Sanofi, Typhen Vi, recall

Sanofi has recalled several lots of its typhoid fever vaccine Typhim Vi on fears that a quality defect could compromise …

News
Bayer image

Bayer signs endometriosis pact

October 3, 2012
Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …

News
Roche and GSK image

Is it really safety first?

October 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …

Feature

Catalent and CTC Partner to Help Korean Pharma Take Their Products to Western Markets

October 2, 2012
Research and Development

Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …

News
Press release

Catalent Enters Into Commerical Supply Agreement with Vivus for Qsymia™ Once-Daily Combination Extended-Release Capsules

October 2, 2012
Manufacturing and Production

Somerset, NJ, October 1, 2012 – Catalent Pharma Solutions announced that it has entered into a Supply Agreement with VIVUS, …

News
Press release
votrient image

Survival boost for Votrient in mRCC

October 2, 2012
Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …

News

Government launches Healthwatch England

October 2, 2012
Sales and Marketing HealthWatch, NHS, government

The government has launched Healthwatch England, a new statutory body whose role is to ensure the public’s voice is heard …

News

Merck Serono has redeployed a fifth of axed Swiss staff

October 2, 2012
Manufacturing and Production Geneva, Merck Serono

Merck Serono says it has redeployed 260 of 1,250 staff affected by the closure and downsizing of sites in Switzerland …

News
Lonza image

Lonza wins contract to make gene therapy for heart failure

October 2, 2012
Manufacturing and Production Celladon, Lonza, Mydicar

Lonza has been awarded a contract by US firm Celladon for the manufacture of Mydicar, a gene therapy-based drug candidate …

News

Sigma-Aldrich invest in Scottish site

October 2, 2012
Manufacturing and Production Bioreliance, Irvine, Scotland, Sigma-Aldrich

Sigma-Aldrich has announced an expansion of its operations in Scotland with the construction of a powder manufacturing facility at its …

News

Pharma manufacturing news in brief

October 2, 2012
Manufacturing and Production BIA Seperations, Hovione, Lonza, Merck Millipore

Hovione invests in particle design, Lonza signs deal for ADC production plus bioprocess news from BIA Separations and Merck Millipore.

News

J&J cancer drugs get EU approval

October 2, 2012
Sales and Marketing Cancer, Dacogen, EU, J&J, JJ, Velcade

Two of Johnson & Johnson’s key cancer drugs have been shown the green light from the European Commission. Janssen-Cilag International’s …

News

Cmed Clinical Services Strengthens Management Team

October 1, 2012
Research and Development

HORSHAM, UK — September 13, 2012 – Cmed Clinical Services has today announced three new appointments to its management team …

News
Press release
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026